| abstract |
The present invention provides a therapeutic agent for atherosclerosis, a therapeutic agent for asthma, a therapeutic agent for allergy, an anti-inflammatory agent and a cytoprotective agent. Compound (I) which is a leukotriene biosynthesis inhibitor: [Wherein X is O or S, Y is O, S—NR 6 —CHR 7 or —NR 8 —C (O) —, A is a 5-membered aromatic heterocycle, 6-membered aromatic heterocycle, Naphthalene or heterobicyclic aromatic ring systems, phenyl and benzyl]. [Selection figure] None |